John A. Lewicki, EVP, Research & Development at OncoMed Pharmaceuticals Inc (OMED), sold 1,248 shares at $4.24 ($5K) on 2017-10-10, disclosed to the SEC on 2017-10-12.
Open-market sale of $5k OMED by EVP, Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.24 | 1,202 | $5K | 96.3% |
| 2 | $4.26 | 46 | $196 | 3.7% |
| Total | $4.24 avg | 1,248 | $5K | 100% |
| Filing → |
| OMED | SELL | 2018-10-11 | $2K | — | Filing → |
| OMED | SELL | 2018-10-10 | $5K | — | Filing → |
| OMED | SELL | 2018-04-26 | $12K | — | Filing → |